| (Values in U.S. Thousands) | Sep, 2025 | Sep, 2024 | Sep, 2023 | Sep, 2022 | Sep, 2021 |
| Sales | 25,260 | 22,180 | 20,130 | 15,540 | 32,310 |
| Sales Growth | +13.89% | +10.18% | +29.54% | -51.90% | +50.14% |
| Net Income | 4,160 | 18,620 | 26,920 | -6,110 | 1,280 |
| Net Income Growth | -77.66% | -30.83% | +540.59% | -577.34% | +101.95% |
Phenixfin Corp Pr
(PFX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
PhenixFIN Corporation is an internally managed, closed-end, business development company. It is focused on current income generation coupled with capital appreciation with a focus on net asset value. PhenixFIN Corporation, formerly known as Medley Capital Corporation, is based in New York.
Fiscal Year End Date: 09/30